{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:02:19Z","timestamp":1780448539729,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T00:00:00Z","timestamp":1775952000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":52,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48643-8","type":"journal-article","created":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T08:47:40Z","timestamp":1775983660000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prebiotic xylooligosaccharides ameliorate metabolic dysfunction-associated steatotic liver disease via modulating gut microbiota and metabolites"],"prefix":"10.1038","volume":"16","author":[{"given":"Li","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ti-Dong","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,12]]},"reference":[{"issue":"1 Suppl","key":"48643_CR1","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne, C. D. & Targher, G. NAFLD: a multisystem disease. J. Hepatol. 62 (1 Suppl), S47\u201364 (2015).","journal-title":"J. Hepatol."},{"issue":"1","key":"48643_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi, Z. et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat. Rev. Gastroenterol. Hepatol. 15 (1), 11\u201320 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"9","key":"48643_CR3","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","volume":"7","author":"K Riazi","year":"2022","unstructured":"Riazi, K. et al. The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis. Lancet Gastroenterol. Hepatol. 7 (9), 851\u2013861 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"1","key":"48643_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4093\/dmj.2024.0042","volume":"49","author":"R Oh","year":"2025","unstructured":"Oh, R. et al. Metabolic Dysfunction-Associated Steatotic Liver Disease and All-Cause and Cause-Specific Mortality. Diabetes Metab. J. 49 (1), 80\u201391 (2025).","journal-title":"Diabetes Metab. J."},{"issue":"7","key":"48643_CR5","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","volume":"24","author":"SL Friedman","year":"2018","unstructured":"Friedman, S. L., Neuschwander-Tetri, B. A., Rinella, M. & Sanyal, A. J. Mechanisms of NAFLD development and therapeutic strategies. Nat. Med. 24 (7), 908\u2013922 (2018).","journal-title":"Nat. Med."},{"issue":"6","key":"48643_CR6","first-page":"729","volume":"84","author":"SJ Keam","year":"2024","unstructured":"Keam, S. J. & Resmetirom First Approval Drugs ;84(6):729\u2013735. (2024).","journal-title":"First Approval Drugs"},{"issue":"5","key":"48643_CR7","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1053\/j.gastro.2013.08.058","volume":"145","author":"LP Smits","year":"2013","unstructured":"Smits, L. P., Bouter, K. E., de Vos, W. M., Borody, T. J. & Nieuwdorp, M. Therapeutic potential of fecal microbiota transplantation. Gastroenterology 145 (5), 946\u2013953 (2013).","journal-title":"Gastroenterology"},{"issue":"Pt A","key":"48643_CR8","doi-asserted-by":"publisher","first-page":"112019","DOI":"10.1016\/j.foodres.2022.112019","volume":"162","author":"A Fuso","year":"2022","unstructured":"Fuso, A. et al. Production of xylo-oligosaccharides (XOS) of tailored degree of polymerization from acetylated xylans through modelling of enzymatic hydrolysis. Food Res. Int. 162 (Pt A), 112019 (2022).","journal-title":"Food Res. Int."},{"issue":"6","key":"48643_CR9","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.3390\/foods10061197","volume":"10","author":"A Fuso","year":"2021","unstructured":"Fuso, A. et al. Potential Valorization of Hazelnut Shells through Extraction, Purification and Structural Characterization of Prebiotic Compounds: A Critical Review. Foods 10 (6), 1197 (2021).","journal-title":"Foods"},{"issue":"7","key":"48643_CR10","doi-asserted-by":"publisher","first-page":"e05361","DOI":"10.2903\/j.efsa.2018.5361","volume":"16","author":"EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)","year":"2018","unstructured":"EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) et al. Safety of xylo-oligosaccharides (XOS) as a novel food pursuant to Regulation (EU) 2015\/2283. EFSA J. 16 (7), e05361 (2018).","journal-title":"EFSA J."},{"issue":"Pt 2","key":"48643_CR11","doi-asserted-by":"publisher","first-page":"132575","DOI":"10.1016\/j.ijbiomac.2024.132575","volume":"271","author":"S Tian","year":"2024","unstructured":"Tian, S., Yang, Z., Yan, F., Xue, X. & Lu, J. Preparation of xylooligosaccharides from rice husks and their structural characterization, antioxidant activity, and probiotic properties. Int. J. Biol. Macromol. 271 (Pt 2), 132575 (2024).","journal-title":"Int. J. Biol. Macromol."},{"key":"48643_CR12","doi-asserted-by":"publisher","first-page":"110529","DOI":"10.1016\/j.foodres.2021.110529","volume":"147","author":"P Jaichakan","year":"2021","unstructured":"Jaichakan, P. et al. Two-stage processing for xylooligosaccharide recovery from rice by-products and evaluation of products: Promotion of lactic acid-producing bacterial growth and food application in a high-pressure process. Food Res. Int. 147, 110529 (2021).","journal-title":"Food Res. Int."},{"issue":"4","key":"48643_CR13","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3945\/jn.112.172361","volume":"143","author":"CH Hansen","year":"2013","unstructured":"Hansen, C. H. et al. Dietary xylooligosaccharide downregulates IFN-\u03b3 and the low-grade inflammatory cytokine IL-1\u03b2 systemically in mice. J. Nutr. 143 (4), 533\u2013540 (2013).","journal-title":"J. Nutr."},{"key":"48643_CR14","doi-asserted-by":"publisher","first-page":"117118","DOI":"10.1016\/j.carbpol.2020.117118","volume":"251","author":"L Santib\u00e1\u00f1ez","year":"2021","unstructured":"Santib\u00e1\u00f1ez, L. et al. Xylooligosaccharides from lignocellulosic biomass: A comprehensive review. Carbohydr. Polym. 251, 117118 (2021).","journal-title":"Carbohydr. Polym."},{"key":"48643_CR15","doi-asserted-by":"crossref","unstructured":"Kumar, V., Bahuguna, A., Kumar, S. & Kim, M. Xylooligosaccharides mediated gut microbiome modulation: prebiotics to postbiotics. Crit. Rev. Biotechnol.17,1\u201319 (2025).","DOI":"10.1080\/07388551.2025.2460852"},{"issue":"7","key":"48643_CR16","doi-asserted-by":"publisher","first-page":"e05361","DOI":"10.2903\/j.efsa.2018.5361","volume":"16","author":"EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)","year":"2018","unstructured":"EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) et al. Safety of xylo-oligosaccharides (XOS) as a novel food pursuant to Regulation (EU) 2015\/2283. EFSA J. 16 (7), e05361 (2018).","journal-title":"EFSA J."},{"issue":"12","key":"48643_CR17","doi-asserted-by":"publisher","first-page":"3617","DOI":"10.1021\/acs.jafc.0c06279","volume":"69","author":"K Berger","year":"2021","unstructured":"Berger, K. et al. Xylooligosaccharides Increase Bifidobacteria and Lachnospiraceae in Mice on a High-Fat Diet, with a Concomitant Increase in Short-Chain Fatty Acids, Especially Butyric Acid. J. Agric. Food Chem. 69 (12), 3617\u20133625 (2021).","journal-title":"J. Agric. Food Chem."},{"key":"48643_CR18","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.aninu.2023.02.002","volume":"13","author":"N Liu","year":"2023","unstructured":"Liu, N. et al. Applications and prospects of functional oligosaccharides in pig nutrition: A review. Anim. Nutr. 13, 206\u2013215 (2023).","journal-title":"Anim. Nutr."},{"key":"48643_CR19","doi-asserted-by":"publisher","first-page":"764556","DOI":"10.3389\/fnut.2021.764556","volume":"8","author":"J Pang","year":"2021","unstructured":"Pang, J. et al. The High Level of Xylooligosaccharides Improves Growth Performance in Weaned Piglets by Increasing Antioxidant Activity, Enhancing Immune Function, and Modulating Gut Microbiota. Front. Nutr. 8, 764556 (2021).","journal-title":"Front. Nutr."},{"key":"48643_CR20","doi-asserted-by":"publisher","first-page":"680208","DOI":"10.3389\/fvets.2021.680208","volume":"8","author":"J Su","year":"2021","unstructured":"Su, J. et al. Dietary Supplementation With Xylo-oligosaccharides Modifies the Intestinal Epithelial Morphology, Barrier Function and the Fecal Microbiota Composition and Activity in Weaned Piglets. Front. Vet. Sci. 8, 680208 (2021).","journal-title":"Front. Vet. Sci."},{"issue":"11","key":"48643_CR21","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.3390\/nu12113225","volume":"12","author":"S Lensu","year":"2020","unstructured":"Lensu, S. et al. Prebiotic Xylo-Oligosaccharides Ameliorate High-Fat-Diet-Induced Hepatic Steatosis in Rats. Nutrients 12 (11), 3225 (2020).","journal-title":"Nutrients"},{"key":"48643_CR22","unstructured":"Food, U. S. & Administration, D. Guidance for industry: Estimating the maximum safe starting dose in initial clinical trials for therapeutics in adult healthy volunteers. Silver Spring, MD: Center for Drug Evaluation and Research; Accessed September 4, 2025. (2005)."},{"issue":"6","key":"48643_CR23","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner, D. E. et al. Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (6), 1313\u20131321 (2005).","journal-title":"Hepatology"},{"issue":"5","key":"48643_CR24","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1002\/hep.25889","volume":"56","author":"P Bedossa","year":"2012","unstructured":"Bedossa, P. et al. Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients. Hepatology 56 (5), 1751\u20131759 (2012).","journal-title":"Hepatology"},{"issue":"D1","key":"48643_CR25","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53 (D1), D672\u2013D677 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"11","key":"48643_CR26","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28 (11), 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"issue":"1","key":"48643_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"48643_CR28","doi-asserted-by":"crossref","unstructured":"Kang, H. et al. Innovative Target Exploration of NAFLD (ITEN) consortium. Interaction effect between NAFLD severity and high carbohydrate diet on gut microbiome alteration and hepatic de novo lipogenesis. Gut Microbes. Jan-Dec;14(1):2078612. (2022).","DOI":"10.1080\/19490976.2022.2078612"},{"issue":"38","key":"48643_CR29","doi-asserted-by":"publisher","first-page":"12014","DOI":"10.1021\/acs.jafc.2c04817","volume":"70","author":"J Sun","year":"2022","unstructured":"Sun, J., Fan, J., Li, T., Yan, X. & Jiang, Y. Nuciferine Protects Against High-Fat Diet-Induced Hepatic Steatosis via Modulation of Gut Microbiota and Bile Acid Metabolism in Rats. J. Agric. Food Chem. 70 (38), 12014\u201312028 (2022).","journal-title":"J. Agric. Food Chem."},{"issue":"3","key":"48643_CR30","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/hep.28356","volume":"63","author":"J Boursier","year":"2016","unstructured":"Boursier, J. et al. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Hepatology 63 (3), 764\u2013775 (2016).","journal-title":"Hepatology"},{"issue":"1","key":"48643_CR31","doi-asserted-by":"publisher","first-page":"e13646","DOI":"10.1111\/obr.13646","volume":"25","author":"X Su","year":"2024","unstructured":"Su, X. et al. Composition of gut microbiota and non-alcoholic fatty liver disease: A systematic review and meta-analysis. Obes. Rev. 25 (1), e13646 (2024).","journal-title":"Obes. Rev."},{"issue":"8","key":"48643_CR32","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00592-020-01669-4","volume":"58","author":"F Del Chierico","year":"2021","unstructured":"Del Chierico, F. et al. Fecal microbiota signatures of insulin resistance, inflammation, and metabolic syndrome in youth with obesity: a pilot study. Acta Diabetol. 58 (8), 1009\u20131022 (2021).","journal-title":"Acta Diabetol."},{"issue":"1","key":"48643_CR33","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/biomedicines10010084","volume":"10","author":"L Wang","year":"2021","unstructured":"Wang, L. et al. Bifidobacterium bifidum Shows More Diversified Ways of Relieving Non-Alcoholic Fatty Liver Compared with Bifidobacterium adolescentis. Biomedicines 10 (1), 84 (2021).","journal-title":"Biomedicines"},{"key":"48643_CR34","doi-asserted-by":"publisher","first-page":"773340","DOI":"10.3389\/fendo.2021.773340","volume":"12","author":"X Long","year":"2021","unstructured":"Long, X. et al. Bifidobacterium adolescentis Alleviates Liver Steatosis and Steatohepatitis by Increasing Fibroblast Growth Factor 21 Sensitivity. Front. Endocrinol. (Lausanne). 12, 773340 (2021).","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"48643_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jbiosc.2019.06.017","volume":"129","author":"M Kawai","year":"2020","unstructured":"Kawai, M. et al. Suppression of lactate production by using sucrose as a carbon source in lactic acid bacteria. J. Biosci. Bioeng. 129 (1), 47\u201351 (2020).","journal-title":"J. Biosci. Bioeng."},{"key":"48643_CR36","doi-asserted-by":"publisher","unstructured":"Higashi, B., Mariano, T. B., de Abreu Filho, B. A., Gon\u00e7alves, R. A. C. & de Oliveira, A. J. B. Effects of fructans and probiotics on the inhibition of Klebsiella oxytoca and the production of short-chain fatty acids assessed by NMR spectroscopy. Carbohydr Polym. ;248:116832. (2020). https:\/\/doi.org\/10.1016\/j.carbpol.2020.116832. Epub 2020 Jul 27. Erratum in: Carbohydr Polym. 2021;260:117568.","DOI":"10.1016\/j.carbpol.2020.116832"},{"key":"48643_CR37","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/BF01575871","volume":"6","author":"T Mitsuoka","year":"1990","unstructured":"Mitsuoka, T. Bifidobacteria and their role in human health. J. Ind. Microbiol. 6, 263\u2013268 (1990).","journal-title":"J. Ind. Microbiol."},{"key":"48643_CR38","doi-asserted-by":"publisher","first-page":"769501","DOI":"10.3389\/fphar.2021.769501","volume":"12","author":"X Li","year":"2021","unstructured":"Li, X., Zhang, B., Hu, Y. & Zhao, Y. New Insights Into Gut-Bacteria-Derived Indole and Its Derivatives in Intestinal and Liver Diseases. Front. Pharmacol. 12, 769501 (2021).","journal-title":"Front. Pharmacol."},{"issue":"18","key":"48643_CR39","doi-asserted-by":"publisher","first-page":"e70061","DOI":"10.1096\/fj.202401172RR","volume":"38","author":"Y Gao","year":"2024","unstructured":"Gao, Y. et al. Indole alleviates nonalcoholic fatty liver disease in an ACE2-dependent manner. FASEB J. 38 (18), e70061 (2024).","journal-title":"FASEB J."},{"key":"48643_CR40","doi-asserted-by":"crossref","unstructured":"Li, M. et al. Gut microbiota metabolite indole-3-acetic acid maintains intestinal epithelial homeostasis through mucin sulfation. Gut Microbes. Jan-Dec;16(1):2377576. (2024).","DOI":"10.1080\/19490976.2024.2377576"},{"issue":"7","key":"48643_CR41","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1007\/s11695-021-05321-0","volume":"31","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Role of Indole-3-Acetic Acid in NAFLD Amelioration After Sleeve Gastrectomy. Obes. Surg. 31 (7), 3040\u20133052 (2021).","journal-title":"Obes. Surg."},{"issue":"1","key":"48643_CR42","doi-asserted-by":"publisher","first-page":"8521","DOI":"10.1038\/s41598-025-92972-z","volume":"15","author":"J Li","year":"2025","unstructured":"Li, J. et al. Identification and verification of biomarkers associated with arachidonic acid metabolism in non-alcoholic fatty liver disease. Sci. Rep. 15 (1), 8521 (2025).","journal-title":"Sci. Rep."},{"key":"48643_CR43","doi-asserted-by":"publisher","first-page":"117177","DOI":"10.1016\/j.ecoenv.2024.117177","volume":"286","author":"X Gong","year":"2024","unstructured":"Gong, X. et al. Unraveling cadmium-driven liver inflammation with a focus on arachidonic acid metabolites and TLR4\/ I\u03baB\u03b1 \/NF-\u03baB pathway. Ecotoxicol. Environ. Saf. 286, 117177 (2024).","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"3","key":"48643_CR44","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.4049\/jimmunol.173.3.1503","volume":"173","author":"Y Kanaoka","year":"2004","unstructured":"Kanaoka, Y. & Boyce, J. A. Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses. J. Immunol. 173 (3), 1503\u20131510 (2004).","journal-title":"J. Immunol."},{"issue":"11","key":"48643_CR45","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1084\/jem.20091240","volume":"206","author":"S Paruchuri","year":"2009","unstructured":"Paruchuri, S. et al. Leukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor. J. Exp. Med. 206 (11), 2543\u20132555 (2009).","journal-title":"J. Exp. Med."},{"issue":"19","key":"48643_CR46","doi-asserted-by":"publisher","first-page":"9916","DOI":"10.1039\/D4FO02158D","volume":"15","author":"Y Ma","year":"2024","unstructured":"Ma, Y. et al. Arachidonic acid enhances hepatocyte bile acid uptake and alleviates cholestatic liver disease by upregulating OATP1 expression. Food Funct. 15 (19), 9916\u20139927 (2024).","journal-title":"Food Funct."},{"issue":"1","key":"48643_CR47","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3920\/BM2009.0025","volume":"1","author":"H M\u00e4kel\u00e4inen","year":"2010","unstructured":"M\u00e4kel\u00e4inen, H. et al. Xylo-oligosaccharides enhance the growth of bifidobacteria and Bifidobacterium lactis in a simulated colon model. Benef Microbes. 1 (1), 81\u201391 (2010).","journal-title":"Benef Microbes"},{"issue":"2","key":"48643_CR48","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3920\/BM2009.0029","volume":"1","author":"H M\u00e4kel\u00e4inen","year":"2010","unstructured":"M\u00e4kel\u00e4inen, H., Saarinen, M., Stowell, J., Rautonen, N. & Ouwehand, A. C. Xylo-oligosaccharides and lactitol promote the growth of Bifidobacterium lactis and Lactobacillus species in pure cultures. Benef Microbes. 1 (2), 139\u2013148 (2010).","journal-title":"Benef Microbes"},{"issue":"8","key":"48643_CR49","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.3390\/ijerph18084049","volume":"18","author":"J Hintikka","year":"2021","unstructured":"Hintikka, J. et al. Xylo-Oligosaccharides in Prevention of Hepatic Steatosis and Adipose Tissue Inflammation: Associating Taxonomic and Metabolomic Patterns in Fecal Microbiomes with Biclustering. Int. J. Environ. Res. Public Health. 18 (8), 4049 (2021).","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"11","key":"48643_CR50","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.3390\/nu12113225","volume":"12","author":"S Lensu","year":"2020","unstructured":"Lensu, S. et al. Prebiotic Xylo-Oligosaccharides Ameliorate High-Fat-Diet-Induced Hepatic Steatosis in Rats. Nutrients 12 (11), 3225 (2020).","journal-title":"Nutrients"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48643-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48643-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48643-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:04:16Z","timestamp":1780445056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48643-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,12]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48643"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48643-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,12]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17027"}}